Breaking News, Collaborations & Alliances

Pall, Servier Enter Biomanufacturing Tie-up

Pall chosen as single-source supplier for Servier’s purpose built end-to-end biomanufacturing facility in Gidy, France

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Pall Corporation, a provider of filtration, separation and purification services, has been chosen by Servier, an independent international pharmaceutical company, as an exclusive technology and services provider for their Gidy, France biomanufacturing facility.   End-to-end solutions from Pall Biotech will be implemented for the development and manufacturing of monoclonal antibodies (mAbs) and recombinant proteins. The facility is part of the Bio-S project at Servier focused on delivering best-i...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters